The consumption of microencapsulated butyrate was reported to reduce the severity of clinical symptoms of diverticulitis, irritable bowel syndrome [34,35,36], and inflammatory bowel disease in adult patients [37], decrease waist circumference and improve insulin sensitivity in obese children [38], and decrease blood pressure in adult diabetic patients [39]. This evidence concerns the gene INS and inflammatory bowel disease.